Pediatric hodgkin lymphoma, version 3.2021

Jamie E. Flerlage; Susan M. Hiniker; Saro Armenian; Ellen C. Benya; Adam J. Bobbey; Vivian Chang; Stacy Cooper; Don W. Coulter; Branko Cuglievan; Bradford S. Hoppe; Leidy Isenalumhe; Kara Kelly; Leslie Kersun; Adam J. Lamble; Nicole A. Larrier; Jeffrey Magee; Kwadwo Oduro; Martha Pacheco; Anita P. Price; Kenneth B. Roberts; Christine M. Smith; Aliyah R. Sohani; Erin M. Trovillion; Emily Walling; Ana C. Xavier; Jennifer L. Burns; Mallory Campbell

doi:10.6004/jnccn.2021.0027

Pediatric hodgkin lymphoma, version 3.2021

Jamie E. Flerlage, Susan M. Hiniker, Saro Armenian, Ellen C. Benya, Adam J. Bobbey, Vivian Chang, Stacy Cooper, Don W. Coulter, Branko Cuglievan, Bradford S. Hoppe, Leidy Isenalumhe, Kara Kelly, Leslie Kersun, Adam J. Lamble, Nicole A. Larrier, Jeffrey Magee, Kwadwo Oduro, Martha Pacheco, Anita P. Price, Kenneth B. RobertsChristine M. Smith, Aliyah R. Sohani, Erin M. Trovillion, Emily Walling, Ana C. Xavier, Jennifer L. Burns, Mallory Campbell

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.

Original language	English (US)
Pages (from-to)	733-754
Number of pages	22
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	19
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2021.0027
State	Published - Jun 2021

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2021.0027

Cite this

Flerlage, J. E., Hiniker, S. M., Armenian, S., Benya, E. C., Bobbey, A. J., Chang, V., Cooper, S., Coulter, D. W., Cuglievan, B., Hoppe, B. S., Isenalumhe, L., Kelly, K., Kersun, L., Lamble, A. J., Larrier, N. A., Magee, J., Oduro, K., Pacheco, M., Price, A. P., ... Campbell, M. (2021). Pediatric hodgkin lymphoma, version 3.2021. JNCCN Journal of the National Comprehensive Cancer Network, 19(6), 733-754. https://doi.org/10.6004/jnccn.2021.0027

Flerlage, JE, Hiniker, SM, Armenian, S, Benya, EC, Bobbey, AJ, Chang, V, Cooper, S, Coulter, DW, Cuglievan, B, Hoppe, BS, Isenalumhe, L, Kelly, K, Kersun, L, Lamble, AJ, Larrier, NA, Magee, J, Oduro, K, Pacheco, M, Price, AP, Roberts, KB, Smith, CM, Sohani, AR, Trovillion, EM, Walling, E, Xavier, AC, Burns, JL & Campbell, M 2021, 'Pediatric hodgkin lymphoma, version 3.2021', JNCCN Journal of the National Comprehensive Cancer Network, vol. 19, no. 6, pp. 733-754. https://doi.org/10.6004/jnccn.2021.0027

@article{d9091245b3294936b1a19b9e6b85d4b1,

title = "Pediatric hodgkin lymphoma, version 3.2021",

abstract = "Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.",

author = "Flerlage, {Jamie E.} and Hiniker, {Susan M.} and Saro Armenian and Benya, {Ellen C.} and Bobbey, {Adam J.} and Vivian Chang and Stacy Cooper and Coulter, {Don W.} and Branko Cuglievan and Hoppe, {Bradford S.} and Leidy Isenalumhe and Kara Kelly and Leslie Kersun and Lamble, {Adam J.} and Larrier, {Nicole A.} and Jeffrey Magee and Kwadwo Oduro and Martha Pacheco and Price, {Anita P.} and Roberts, {Kenneth B.} and Smith, {Christine M.} and Sohani, {Aliyah R.} and Trovillion, {Erin M.} and Emily Walling and Xavier, {Ana C.} and Burns, {Jennifer L.} and Mallory Campbell",

year = "2021",

month = jun,

doi = "10.6004/jnccn.2021.0027",

language = "English (US)",

volume = "19",

pages = "733--754",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "6",

}

TY - JOUR

T1 - Pediatric hodgkin lymphoma, version 3.2021

AU - Flerlage, Jamie E.

AU - Hiniker, Susan M.

AU - Armenian, Saro

AU - Benya, Ellen C.

AU - Bobbey, Adam J.

AU - Chang, Vivian

AU - Cooper, Stacy

AU - Coulter, Don W.

AU - Cuglievan, Branko

AU - Hoppe, Bradford S.

AU - Isenalumhe, Leidy

AU - Kelly, Kara

AU - Kersun, Leslie

AU - Lamble, Adam J.

AU - Larrier, Nicole A.

AU - Magee, Jeffrey

AU - Oduro, Kwadwo

AU - Pacheco, Martha

AU - Price, Anita P.

AU - Roberts, Kenneth B.

AU - Smith, Christine M.

AU - Sohani, Aliyah R.

AU - Trovillion, Erin M.

AU - Walling, Emily

AU - Xavier, Ana C.

AU - Burns, Jennifer L.

AU - Campbell, Mallory

PY - 2021/6

Y1 - 2021/6

N2 - Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.

AB - Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.

UR - http://www.scopus.com/inward/record.url?scp=85110148128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110148128&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2021.0027

DO - 10.6004/jnccn.2021.0027

M3 - Review article

C2 - 34214968

AN - SCOPUS:85110148128

SN - 1540-1405

VL - 19

SP - 733

EP - 754

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Pediatric hodgkin lymphoma, version 3.2021

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this